Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


ELRIG - Drug Discovery 2014

02 Sep 2014 - 03 Sep 2014 - Manchester, UK



Bookmark and Share


The scientific sessions will include Innovations in Assay Development, Oncology Drug Discovery, Target Validation and Engineered Proteins for Therapy.

We are delighted to introduce three new science sessions this year, which will cover cutting-edge thinking in several therapeutic and discovery opportunities and techniques - Phenotypic Discovery & Cellular Imaging, Neuroscience Drug Targets, and Chemistry Innovation in Lead Discovery.

Another exciting addition to our conference this year is a series of Core Technologies Workshops. These will provide a more informal, interactive environment for you to discuss key issues and future directions in Innovative Automation, Complex Data, Sample Management, and Safety & Metabolism Screening, in workshops coordinated by leaders in the fields.

ELRIG Drug Discovery 2014 will include a high quality scientific poster session, networking opportunities, and an extensive vendor exhibition.

Each year, the ELRIG Drug Discovery conference provides a fantastic communication and learning opportunity for scientists engaged in research fields across drug discovery, bringing together  Academia, Biotech, Vendors, & Pharma, into a single community of scientists. It is now well established as the leading annual drug discovery event held in the UK.



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Vaccine Against Common Cold Achievable
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
New Weapon Against Hard-to-Treat Bacterial Infections
Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
GSK’s Shingles Vaccine Candidate Shows High Efficacy
The vaccine candidate showed high efficacy against shingles and its complications in adults aged 70yrs+ in phase III study.
Novavax RSV F Vaccine Fails Phase 3 Trial
Novavax announces topline RSV F Vaccine data from two clinical trials in older adults.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!